fda glp-1 warning news november 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes FDA warns consumers not to

The following day medium was removed and replaced with 20 l of loading medium consisting of 1:1 (v/v) Opti-MEM: Hanks balanced salt solution (HBSS), 2.5% (v/v) FBS, 20 mM HEPES, pH 7.4, 2.5 mM probenicid and fluorescent indicator 2 M Fluo-4 AM (Invitrogen)

They include: Surgery to remove the stomach (including weight loss surgery) or the end of the small intestine

GLP-1 agonists, such as Semaglutide GLP-1 ( Ozempic ), Liraglutide, and Exenatide, mimic the actions of a natural hormone released by the gut after eating

Total weight loss from baseline to week 52 was 6.7% in the placebo group, 10.9% with exercise alone, 13.4% with liraglutide alone, and 15.7% with combination therapy